Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ogino

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Journal of Steroid Biochemistry|January 1, 1989
In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)H Honjo, Y Ogino, K Naitoh, et al.
Bioorganic & Medicinal Chemistry|May 20, 2000
Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivativesM Mitsuya, Y Ogino, K Kawakami, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1995
[Phase 3 multicenter clinical study of 111In-DTPA-D-octreotide (MP-1727) in patients with gastrointestinal hormone producing tumors]K Yamamoto, Y Ishii, M Furudate, et al.
The New Biologist|February 1, 1991
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretionH Ehrenreich, R W Anderson, Y Ogino, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 21, 1998
Aberrant regulation of bone trace elements in motheaten and osteopetrosis mutant miceG Yamada, S Nakamura, R Haraguchi, et al.
Oncogene|September 5, 2012
β-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formationM Villacorte, K Suzuki, A Hirasawa, et al.
Bioorganic & Medicinal Chemistry|January 13, 2000
J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptorsM Mitsuya, T Mase, Y Tsuchiya, et al.
British Journal of Anaesthesia|September 13, 2005
Hypoalbuminaemia and propofol pharmacokineticsD Takizawa, E Sato, N Ito, et al.
Journal of Medicinal Chemistry|January 11, 2001
A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptorsM Mitsuya, K Kobayashi, K Kawakami, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Journal of Steroid Biochemistry|January 1, 1989
In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)H Honjo, Y Ogino, K Naitoh, et al.
Bioorganic & Medicinal Chemistry|May 20, 2000
Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivativesM Mitsuya, Y Ogino, K Kawakami, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1995
[Phase 3 multicenter clinical study of 111In-DTPA-D-octreotide (MP-1727) in patients with gastrointestinal hormone producing tumors]K Yamamoto, Y Ishii, M Furudate, et al.
The New Biologist|February 1, 1991
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretionH Ehrenreich, R W Anderson, Y Ogino, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 21, 1998
Aberrant regulation of bone trace elements in motheaten and osteopetrosis mutant miceG Yamada, S Nakamura, R Haraguchi, et al.
Oncogene|September 5, 2012
β-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formationM Villacorte, K Suzuki, A Hirasawa, et al.
Bioorganic & Medicinal Chemistry|January 13, 2000
J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptorsM Mitsuya, T Mase, Y Tsuchiya, et al.
British Journal of Anaesthesia|September 13, 2005
Hypoalbuminaemia and propofol pharmacokineticsD Takizawa, E Sato, N Ito, et al.
Journal of Medicinal Chemistry|January 11, 2001
A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptorsM Mitsuya, K Kobayashi, K Kawakami, et al.
Pageof 13